# PRESTIGE CONSUMER HEALTHCARE INC. (PBH) · Edgar & Edgarette company card

> Prestige Consumer Healthcare (PBH) saw revenue fall 4.3% in FY2026 to $1.1 billion, operating margin 28.4% against a -3.8% median for pharmaceutical preparations, equity 54.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1295947 · fiscal year ended 2026-03-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PBH) · [JSON](https://www.pops4.com/boards/company/PBH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.1B |
| Revenue growth, 1 year | -4.3% |
| Revenue growth per year | 0.0% |
| Operating margin | 28.4% (prior year 29.6%) |
| Net margin | 17.5% |
| Operating cash flow | $258M |
| Capital spending | $11M |
| Free cash flow | $246M |
| Cash | $64M |
| Long-term debt | $994M |
| Total assets | $3.5B |
| Total equity | $1.9B |
| Equity ÷ assets | 54.0% |
| Return on equity | 10.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.04 (safe zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $1.1B (FY2026), total debt $994.0M. Experience: revenue down 4.3% on the year, up 0.0% a year over 4 years; operating margin 28.4%, down from 29.6%. Soundness: equity 54.0% of assets, return on equity 10.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $925.8M and $1.2B next year (method v4.1: its own 5-year record of growth weighed at 57% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $853.7M to $1.3B. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin 28.4% against a -3.8% median; growth -4.3% against 13.7%.

Range logged 2026-11-01, receipt 8017f7697d09fb03, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000049/0001295947-26-000049-index.htm))

## Recent filings

- 8-K · filed 2026-08-14 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000049/0001295947-26-000049-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000042/0001295947-26-000042-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/0001295947-26-000040-index.htm)
- 8-K · filed 2026-07-15 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000110465926083872/0001104659-26-083872-index.htm)
- 8-K · filed 2026-07-06 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/0001295947-26-000029-index.htm)
- DEF 14A · filed 2026-06-29 · [filing](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000021/0001295947-26-000021-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001295947.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1295947

## Cite

POPS4, Edgar & Edgarette: PRESTIGE CONSUMER HEALTHCARE INC. (PBH) company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/PBH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.